Cipla in talks with Eli Lilly for diabetes drug, say sources; shares in green
Published on 25/08/2025 03:03 PM
Cipla share price news, Cipla-Eli Lilly News: Cipla is in talks with US-based Eli Lilly to manufacturer Semaglutide and Ozempic -- anti-diabetic medications -- in India, sources told Zee Business. The Cipla stock held on firmly to the green after the news.
Initially, Eli Lilly will share technology with Cipla, which will later produce these drugs on its own, added the sources.
There is strong demand for Ozempic in the country.
Add Zee Business as a Preferred Source
At the time of publishing this report, queries emailed to Cipla remained unanswered.
At 2:45 pm, the Cipla stock traded higher by Rs 9.7, or 0.6 per cent, for the day, at Rs 1,602 apiece on BSE. having gained as much as 1.0 per cent to Rs 1,607.6 apiece in intraday trade so far.
The pharma stock traded with moderate volumes with about 17,000 shares having changed hands on BSE for the day, lower than a daily average of 44,000 recorded in the past two weeks, according to provisional exchange data.
At the current level, Cipla shares have risen 4.8 per cent so far in 2025, in line with a 5.2 per cent gain in the Nifty50 though outperforming a 4.7 per cent in the Nifty Pharma.Last month, the Mumbai-based pharmaceutical firm staged a strong financial performance for the first quarter of the current financial year.Its consolidated net profit grew 10.2 per cent to Rs 1,298 crore, beating analysts' expectations.
ALSO READ: Cipla Q1 FY26 Results | With Rs 1,298 crore Q1 profit, Mumbai-based pharma company beats Street estimates
Most analysts view Cipla shares positively.
Brokerage Axis Direct has a 'buy' call assigned to the Cipla stock with a target price of Rs 1,700.
At Friday's closing price, the target suggests an upside of 6.8 per cent in the largecap pharma stock.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
LATEST NEWSBy accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.